BAYESIAN CAPITAL MANAGEMENT, LP – Halozyme Therapeutics, Inc. Transaction History
BAYESIAN CAPITAL MANAGEMENT, LP portfolio value:
$637,000
portfolio value
BAYESIAN CAPITAL MANAGEMENT, LP quarter portfolio value change:
-10.14%
quarter
Halozyme Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -19.10% | -3.8K shares | -239K | $39.54 | 16.1K |
| Q2 2022 | share | Increase | 0.00% | 19.9K shares | 876K | $44 | 19.9K |
| Q3 2021 | share | Decrease | -100.00% | -7.8K shares | -354K | $40.68 | 0 |
| Q2 2021 | share | Decrease | -7.86% | -665 shares | 1K | $45.41 | 7.8K |
| Q1 2021 | share | Increase | 0.00% | 8.46K shares | 353K | $41.69 | 8.46K |
| Q1 2018 | share | Decrease | -100.00% | -22.8K shares | -462K | $19.59 | 0 |
| Q4 2017 | share | Increase | 0.00% | 22.8K shares | 462K | $20.26 | 22.8K |
| Q3 2016 | share | Decrease | -100.00% | -11.2K shares | -97K | $12.08 | 0 |
| Q2 2016 | share | Increase | 0.00% | 11.2K shares | 97K | $8.63 | 11.2K |